Development of a multicomponent candidate vaccine for HIV-1

By Kim J.J.   Ayyavoo V.   Bagarazzi M.L.   Chattergoon M.   Boyer J.D.   Bin W.   Weiner D.B.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 879-883

Elsevier

Access to resources Recommend Favorite

Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies

By Jones D.H.   McBride B.W.   Roff M.A.   Farrar G.H.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 991-999

Elsevier

Access to resources Recommend Favorite

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

By Kojima Y.   Xin K.-Q.   Ooki T.   Hamajima K.   Oikawa T.   Shinoda K.   Ozaki T.   Hoshino Y.   Jounai N.   Nakazawa M.   Klinman D.   Okuda K.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2857-2865

Elsevier

Access to resources Recommend Favorite

Molecular surveillance of HIV-1 field strains in Nigeria in preparation for vaccine trials

By Agwale S.M.   Zeh C.   Robbins K.E.   Odama L.   Saekhou A.   Edubio A.   Njoku M.   Sani-Gwarzo N.   Gboun M.S.   Gao F.   Reitz M.   Hone D.   Pieniazek D.   Wambebe C.   Kalish M.L.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2131-2139

Elsevier

Access to resources Recommend Favorite

Immunogenicity of an HIV-1 gag DNA vaccine carried by attenuated Shigella

By Xu F.   Hong M.   Ulmer J.B.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 644-648

Elsevier

Access to resources Recommend Favorite